Chemomab Therapeutics Ltd.
CMMB
Price:
$2.5432
Market Cap:
$15.65M
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
Industry
Biotechnology
IPO Date
2019-02-12
Stock Exchange
NASDAQ
Ticker
CMMB
PE Ratio
[-1.77]
ROE
[-89.92%]
Current Ratio
[10.49]
Dividend Yield
[0%]
Enterprise Value
[8.68M]
Dividend History
The ROE as of December 2025 (TTM) for Chemomab Therapeutics Ltd. (CMMB) is -89.92%
According to Chemomab Therapeutics Ltd.’s latest financial reports and current stock price. The company's current ROE is -89.92%. This represents a change of 297.10% compared to the average of -22.65% of the last 4 quarters.
Chemomab Therapeutics Ltd. (CMMB) Historical ROE (quarterly & annually)
How has CMMB ROE performed in the past?
The mean historical ROE of Chemomab Therapeutics Ltd. over the last ten years is 35.89%. The current -89.92% ROE has changed -350.59% with respect to the historical average. Over the past ten years (40 quarters), CMMB's ROE was at its highest in in the December 2019 quarter at 119.13%. The ROE was at its lowest in in the June 2024 quarter at -36.36%.
Average
35.89%
Median
-121.87%
Minimum
-349.71%
Maximum
1.61%
Chemomab Therapeutics Ltd. (CMMB) ROE by Quarter and Year
Discovering the peaks and valleys of Chemomab Therapeutics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 275.96%
Maximum Annual ROE = 1.61%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -349.71%
| Year | ROE | Change |
|---|---|---|
| 2024 | -103.01% | -27.71% |
| 2023 | -142.50% | 86.71% |
| 2022 | -76.32% | 275.96% |
| 2021 | -20.30% | -63.15% |
| 2020 | -55.09% | -74.95% |
| 2019 | -219.93% | 56.28% |
| 2018 | -140.72% | -108.74% |
| 2017 | 1.61% | -1220.23% |
| 2016 | -143.74% | -58.90% |
| 2015 | -349.71% | -Infinity% |
Chemomab Therapeutics Ltd. (CMMB) Average ROE
How has CMMB ROE performed in the past?
The current ROE of Chemomab Therapeutics Ltd. (CMMB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-107.28%
5-year avg
-79.45%
10-year avg
35.89%
Chemomab Therapeutics Ltd. (CMMB) ROE vs. Peers
How is CMMB’s ROE compared to its peers?
Chemomab Therapeutics Ltd.’s ROE is less than Kazia Therapeutics Limited (335.37%), less than Ocean Biomedical, Inc. (32.26%), greater than Theriva Biologics, Inc. (-169.32%), greater than PMGC Holdings Inc. (-50.79%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than BioVie Inc. (-82.81%), greater than XORTX Therapeutics Inc. (-73.46%), greater than InMed Pharmaceuticals Inc. (-93.20%), less than CERo Therapeutics Holdings, Inc. (989.65%), greater than Galmed Pharmaceuticals Ltd. (-48.35%),
| Company | ROE | Market cap |
|---|---|---|
| 335.37% | $22.67M | |
| 32.26% | $593.18K | |
| -169.32% | $8.24M | |
| -50.79% | $2.10M | |
| -182.93% | $3.49M | |
| -82.81% | $11.83M | |
| -73.46% | $2.54M | |
| -93.20% | $2.41M | |
| 989.65% | $144.64K | |
| -48.35% | $6.19M |
Build a custom stock screener for Chemomab Therapeutics Ltd. (CMMB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chemomab Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Chemomab Therapeutics Ltd. (CMMB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Chemomab Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Chemomab Therapeutics Ltd.'s ROE?
How is the ROE calculated for Chemomab Therapeutics Ltd. (CMMB)?
What is the highest ROE for Chemomab Therapeutics Ltd. (CMMB)?
What is the 3-year average ROE for Chemomab Therapeutics Ltd. (CMMB)?
What is the 5-year average ROE for Chemomab Therapeutics Ltd. (CMMB)?
How does the current ROE for Chemomab Therapeutics Ltd. (CMMB) compare to its historical average?